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SelectivityA pronounced membrane selectivity is demonstrated for short, hydrophilic, and highly charged antimicrobial
peptides, end-tagged with aromatic amino acid stretches. The mechanisms underlying this were investigated
by a method combination of ﬂuorescence and CD spectroscopy, ellipsometry, and Langmuir balance
measurements, as well as with functional assays on cell toxicity and antimicrobial effects. End-tagging with
oligotryptophan promotes peptide-induced lysis of phospholipid liposomes, as well as membrane rupture
and killing of bacteria and fungi. This antimicrobial potency is accompanied by limited toxicity for human
epithelial cells and low hemolysis. The functional selectivity displayed correlates to a pronounced selectivity
of such peptides for anionic lipid membranes, combined with a markedly reduced membrane activity in the
presence of cholesterol. As exempliﬁed for GRR10W4N (GRRPRPRPRPWWWW-NH2), potent liposome
rupture occurs for anionic lipid systems (dioleoylphosphatidylethanolamine (DOPE)/dioleoylphosphatidyl-
glycerol (DOPG) and Escherichia coli lipid extract) while that of zwitterionic dioleoylphosphatidylcholine
(DOPC)/cholesterol is largely absent under the conditions investigated. This pronounced membrane
selectivity is due to both a lower peptide binding to the zwitterionic membranes (z≈−8–10 mV) than to
the anionic ones (z≈−35–40 mV), and a lower degree of membrane incorporation in the zwitterionic
membranes, particularly in the presence of cholesterol. Replacing cholesterol with ergosterol, thus mimicking
fungal membranes, results in an increased sensitivity for peptide-induced lysis, in analogy to the antifungal
properties of such peptides. Finally, the generality of the high membrane selectivity for other peptides of this
type is demonstrated.46 184714377.
. Malmsten).
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Antimicrobial peptides (AMPs) are currently receiving consider-
able attention due to increasing antibiotics resistance development,
where efforts are directed to identifying potent and selective AMPs,
e.g., through quantitative structure–activity relationships or through
identiﬁcation of AMPs of endogenous origin [1–8]. Although AMPs
inﬂuence bacteria in a number of ways, membrane rupture is a key
action mechanism for these peptides [2–8]. Since bacterial mem-
branes are rich in anionic phospholipids, while human cell mem-
branes are dominated by zwitterionic ones, some AMP selectivity can
be obtained for positively charged and hydrophilic AMPs. However, a
number of important pathogens, e.g., Staphylococcus aureus, display a
low electrostatic surface potential, which may be reduced or even
reversed [6]. Furthermore, due to electrostatic screening, the
bactericidal potency of such peptides at physiological ionic strength
is typically limited. Through increasing AMP hydrophobicity thisinactivation at high ionic strength may be reduced, although highly
hydrophobic AMPs have been found to be less selective in their action,
thus displaying signiﬁcant toxicity [4]. Given this, we previously
identiﬁed end-tagging of AMPs with hydrophobic amino acid
stretches [10–12] as away to promote peptide binding andmembrane
disruption, and to reduce salt sensitivity of AMPs. Such peptides were
demonstrated to display limited toxicity combined with high
microbicidal potency of broad spectrum, also at physiological ionic
strength and in the presence of serum, as well as ex vivo and in vivo.
While it could be demonstrated that the potency of these peptides
was due to the hydrophobic end-tagging promoting peptide adsorp-
tion at phospholipid membranes, the ﬁner details of the effect of the
hydrophobic modiﬁcations remained to be elucidated.
Given this, the present study aims to bring this work further by
investigating the effects of end-tagging of short, hydrophilic, and
highly charged AMPs on peptide incorporation into phospholipid
membranes of different composition. In doing so, we employ a
method combination of liposome leakage assay, ellipsometry, CD and
ﬂuorescence spectroscopy, and Langmuir balance, aimed at elucidat-
ing effects of lipid membrane composition on peptide adsorption to,
incorporation into, and rupture of the membranes, and how this
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peptide GRRPRPRPRP (derived from human proline arginine-rich and
leucine-rich repeat protein (PRELP) [13]) as an illustrating example,
we demonstrate that short, hydrophilic, and highly charged AMPs
may display pronounced selectivity for bacteria and fungi when end-
tagged with aromatic amino acid stretches, which can be largely
understood as originating from effects of membrane charge, as well as
presence and identity of sterol, on peptide-membrane interactions.
2. Experimental
2.1. Peptides
Peptides (Table 1) were synthesized by Biopeptide Co., San Diego,
CA,with the exceptionof LL-37,whichwasobtained from InnovagenAB,
Lund, Sweden. Peptides used were all of N95% purity, as evidenced by
mass spectral analysis (MALDI-TOF Voyager). LL-37 (LLGDFFRKSKE-
KIGKEFKRIVQRIKDFLRNLVPRTES) and omiganan (ILRWPWWPWRRK-
NH2)were chosen as control peptides, LL-37 since this is one of themost
widely investigated AMPs in literature, and omiganan since this peptide
has undergone late stage clinical development and testing, hence a
suitable reference peptide from a therapeutic perspective.
2.2. Microorganisms
Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 29213,
Pseudomonas aeruginosa ATCC 27853, Candida albicans 90028, and
Candida parapsilosis 90015 clinical isolates were obtained from the
Department of Clinical Bacteriology at Lund University Hospital,
Sweden.
2.3. Radial diffusion assay
Essentially as described previously [14,15], bacteria were grown to
mid-logarithmic phase in 10 ml of full-strength (3% w/v) trypticase
soy broth (TSB) (Becton-Dickinson, Cockeysville, MD). The micro-
organisms were then washed once with 10 mM Tris, pH 7.4, with
additional 150 mM NaCl. Subsequently, 4×106 colony forming units
(cfu) were added to 15 ml of the underlay agarose gel, consisting of
0.03% (w/v) TSB, 1% (w/v) low electroendosmosis type (EEO) agarose
(Sigma-Aldrich, St. Louis, MO), and 0.02% (v/v) Tween 20 (Sigma-
Aldrich, St. Louis, MO). The underlay was poured into a Ø 144 mm
Petri dish. After agarose solidiﬁcation, 4-mm-diameter wells were
punched and 6-μl peptide solution of required concentration added to
each well. Plates were incubated at 37 °C for 3 h to allow peptide
diffusion. The underlay gel was then covered with 15 ml of molten
overlay (6% TSB and 1% Low-EEO agarose in distilled H2O).
Antimicrobial activity of a peptide was visualized as a zone of clearing
around each well after 18–24 h of incubation at 37 °C.Table 1
Primary structure and key properties of the peptides investigated.
Sequence IP Znet2
(pH 7.4)
H3
GRR10 GRRPRPRPRP 12.60 +5 -0.89
GRR10N GRRPRPRPRP-NH2 12.60 +5 -0.89
GRR10W4N GRRPRPRPRPWWWW-NH2 12.60 +5 -0.53
GKK10W4N GKKPKPKPKPWWWW 10.60 +5 -0.29
GRR10F5 GRRPRPRPRPFFFFF 12.60 +5 -0.39
KNK10W3 KNKGKKNGKHWWW 10.60 +5 -0.44
LL-37 LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES 11.09 +6 -0.34
Omiganan ILRWPWWPWRRK-NH2 12.64 +4 -0.31
WWW WWW 6.0 -1 0.81
1IP: isoelectric point; 2Znet: net charge; 3H mean hydrophobicity on the Eisenberg scale
[53].2.4. Viable count analysis
S. aureus ATCC 29213 were grown to mid-logarithmic phase in
Todd–Hewitt (TH) medium, while P. aeruginosa ATCC 27853 were
grown in TH overnight. Bacteria were washed and diluted in 10 mM
Tris, pH 7.4, 5 mM glucose, 0.15 M NaCl. 50 μl of 2×106 cfu/ml
bacteria were incubated at 37 °C for 2 h in the presence of peptide at
the indicated concentrations. Serial dilutions of the incubation
mixture were plated on TH agar, followed by incubation at 37 °C
overnight and cfu determination. For further evaluation of bactericidal
effects, P. aeruginosa ATCC 27853 and S. aureus ATCC 29213 were
grown to mid-logarithmic phase in Todd–Hewitt (TH) medium.
Bacteria were washed and diluted in 10 mM Tris, pH 7.4, 5 mM
glucose, 0.15 M NaCl, with 20% human citrate plasma (50 ml; 2×106
cfu/ml). After exposure to GRR10W4N, serial dilutions of the
incubation mixture were plated on TH agar, followed by incubation
at 37 °C overnight and cfu determination. In the experiments using
50% whole blood, S. aureus ATCC 29213 and P. aeruginosa ATCC 27853
bacteria (50 μl; 2×108 cfu/ml) were incubated at 37 °C for 1 h in the
presence of peptide at 60 and 120 μM. Serial dilutions of the
incubation mixture were plated on TH agar, followed by incubation
at 37 °C overnight and cfu determination.
2.5. Minimal inhibitory concentration (MIC) determination
In order to determine the minimal inhibitory concentration (MIC)
for a given peptide and bacteria, we used a standardized dilution
method according to NCSLA guidelines. In brief, fresh overnight
colonies were suspended to a turbidity of 0.5 units and further diluted
inMueller-Hinton broth (MH) (Becton-Dickinson). For determination
of MIC, peptides were dissolved in water at concentration 10 times
higher than the required rangeby serial dilutions froma stock solution.
Ten microliters of each concentration was added to each
corresponding well of a 96-well microtiter plate (polypropylene,
Costar Corp.) and 90 μl of bacteria (1×105) in MHmedium added. The
plate was incubated at 37 °C for 16–18 h. MIC was considered as the
lowest concentrationwhere no visual growth of bacteriawas detected.
2.6. MTT assay
Sterile ﬁltered MTT (3-(4,5-dimethylthiazolyl)-2,5-diphenyl-
tetrazolium bromide; Sigma-Aldrich, St. Louis, MO) solution (5 mg/ml
in PBS) was stored protected from light at −20 °C until usage. HaCaT
keratinocytes, 3000 cells/well, were seeded in 96-well plates and grown
in keratinocyte-SFM/BPE-rEGF medium to conﬂuence. Keratinocyte-
SFM/BPE-rEGFmedium alone, or keratinocyte-SFM supplementedwith
20% serum, was added, followed by peptide addition to 60 μM. After
incubation over night, 20 μl of theMTT solution was added to each well
and the plates incubated for 1 h in CO2 at 37 °C. The MTT-containing
medium was then removed by aspiration. The blue formazan product
generated was dissolved by the addition of 100 μl of 100% DMSO per
well. The plates were then gently swirled for 10 min at room
temperature to dissolve the precipitate. The absorbance wasmonitored
at 550 nm, and results given represent mean values from triplicate
measurements.
2.7. Lactate dehydrogenase (LDH) assay
HaCaT keratinocytes were grown in 96 well plates (3000 cells/
well) in serum-free keratinocyte medium (SFM) supplemented with
bovine pituitary extract and recombinant EGF (BPE-rEGF) (Invitrogen,
Eugene, OR) to conﬂuency. The medium was then removed, and
100 μl of the peptides investigated (at 60 μM, diluted in SFM/BPE-rEGF
or in keratinocyte-SFM supplemented with 20% human serum) added
in triplicates to different wells of the plate. The LDH-based TOX-7 kit
(Sigma-Aldrich, St. Louis, MO) was used for quantiﬁcation of LDH
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triplicate measurements and are given as fractional LDH release
compared to the positive control consisting of 1% Triton X-100
(yielding 100% LDH release).
2.8. Hemolysis assay
EDTA-blood was centrifuged at 800×g for 10 min, whereafter
plasma and buffy coat were removed. The erythrocytes were washed
three times and resuspended to 5% in PBS, pH 7.4. For experiments in
50% blood, citrate–blood was diluted (1:1) with PBS. The cells were
then incubated with end-over-end rotation for 1 h at 37 °C in the
presence of peptides (60 or 120 μM). 2% Triton X-100 (Sigma-Aldrich,
St. Louis, MO) served as positive control. The samples were then
centrifuged at 800×g for 10 min. The absorbance of hemoglobin
release was measured at 540 nm and is expressed as percentage of
TritonX-100 induced hemolysis. Results given represent mean values
from triplicate measurements. In the experiments with blood infected
by bacteria, citrate–blood was diluted (1:1) with PBS. The cells were
then incubated with end-over-end rotation for 1 h at 37 °C in the
presence of peptides (60 and 120 μM) and S. aureus (2×108 cfu/ml) or
P. aeruginosa (2×108 cfu/ml) bacteria. For evaluation of hemolysis,
samples were then processed as above.
2.9. Liposome preparation and leakage assay
The liposomes investigated were either zwitterionic (DOPC/
cholesterol 60/40 mol/mol, DOPC/ergosterol 60/40 mol/mol, or
DOPC without cholesterol) or anionic (DOPE/DOPG 75/25 mol/mol,
or Eschirichia coli lipid extract). DOPG (1,2-dioleoyl-sn-glycero-3-
phosphoglycerol, monosodium salt), DOPE (1,2-dioleoyl-sn-glycero-
3-phoshoetanolamine), and DOPC (1,2-dioleoyl-sn-glycero-3-
phoshocholine) were all from Avanti Polar Lipids (Alabaster, AL)
and of N99% purity, while cholesterol and ergosterol (both of N99%
purity), were from Sigma-Aldrich (St. Louis, MO). In addition,
reconstituted lipid membranes were used based on polar extract of
E. coli with a lipid composition of 67.0% phosphatidylethanolamine,
23.2% phosphatidylglycerol, and 9.8% diphosphatidylglycerol (Avanti
Polar Lipids, Alabaster, AL). The lipid mixtures were dissolved in
chloroform, after which solvent was removed by evaporation under
vacuum overnight. Subsequently, 10 mM Tris buffer, pH 7.4 (with or
without 150 mM NaCl), was added together with 0.1 M carboxy-
ﬂuorescein (CF) (Sigma, St. Louis, MO). After hydration, the lipid
mixture was subjected to eight freeze–thaw cycles (not for E. coli
liposomes) consisting of freezing in liquid nitrogen and heating to
60 °C. Unilamellar liposomes of about Ø140 nm were generated by
multiple extrusions (30 passages) through polycarbonate ﬁlters (pore
size 100 nm) mounted in a LipoFast miniextruder (Avestin, Ottawa,
Canada) at 22 °C. Cryo-TEM shows predominantly unilamellar
liposomes, with little multilamellar liposomes and non-closed
aggregates. This is compatible with both dynamic light scattering
and excellent liposome inclusion stability. Together, these ﬁndings
indicate efﬁcient membrane closure of the lamellar structure.
Untrapped CF was removed by two subsequent gel ﬁltrations
(Sephadex G-50, GE Healthcare, Uppsala, Sweden) at 22 °C, with
Tris buffer (with or without 150 mM NaCl) as eluent. Thus, the
osmotic pressure gradient over the membrane due to entrapped CF is
the same in the absence and presence of 150 mM NaCl, and between
the different liposomes, and does not inﬂuence the comparisons
made. CF release from the liposomes was determined by monitoring
the emitted ﬂuorescence at 520 nm from a liposome dispersion
(10 μM lipid in 10 mM Tris, pH 7.4). An absolute leakage scale was
obtained by disrupting the liposomes at the end of each experiment
through addition of 0.8 mM Triton X-100 (Sigma-Aldrich, St. Louis,
MO). A SPEX-ﬂuorolog 1650 0.22-m double spectrometer (SPEXIndustries, Edison, NJ) was used for the liposome leakage assay.
Measurements were performed in triplicate at 37 °C.
2.10. Fluorescence spectroscopy
Tryptophan ﬂuorescence spectra were determined by a SPEX
Fluorolog-2 spectroﬂuorometer at a peptide concentration of 10 μM.
An excitation wavelength of 280 nmwas used, while emission spectra
were taken between 300 and 450 nm. Measurements were conducted
at 37 °C while stirring in 10 mM Tris, pH 7.4, with or without 150 mM
NaCl. Where indicated, liposomes (100 μM lipid) were included,
incubated with the peptides for 1 h before measurements were
initiated. Spectra intensities were normalized to those for 10 mM Tris,
pH 7.4, in order to facilitate comparison of spectral maximum
positions.
2.11. CD spectroscopy
Circular dichroism (CD) spectra were measured by a Jasco J-810
Spectropolarimeter (Jasco, Easton, MD). The measurements were
performed in duplicate at 37 °C in a 10 mm quartz cuvette under
stirring with a peptide concentration of 10 μM. The effect on peptide
secondary structure of liposomes at a lipid concentration of 100 μM
was monitored in the range 200–260 nm. To account for instrumental
differences between measurements, the background value (detected
at 250 nm,where no peptide signal is present) was subtracted. Signals
from the bulk solution were also corrected for. (Substraction of the
entire background spectra instead does not appreciably inﬂuence
peptide spectra).
2.12. Ellipsometry
Peptide adsorption to supported lipid bilayers was studied in situ
by null ellipsometry, using an Optrel Multiskop (Optrel, Kleinmach-
now, Germany) equipped with a 100 mW argon laser. All measure-
ments were carried out at 532 nm and an angle of incidence of 67.66°
in a 5-ml cuvette under stirring (300 rpm). Both the principles of null
ellipsometry and the procedures used have been described exten-
sively before [16,17]. In brief, by monitoring the change in the state of
polarization of light reﬂected at a surface in the absence and presence
of an adsorbed layer, themean refractive index (n) and layer thickness
(d) of the adsorbed layer can be obtained. From the thickness and
refractive index the adsorbed amount (Γ) was calculated according to
[18]
Γ =
n−n0ð Þ
dn= dc
d; ð1Þ
where dn/dc is the refractive index increment (0.154 cm3/g) and n0 is
the refractive index of the bulk solution. Corrections were routinely
done for changes in bulk refractive index caused by changes in
temperature and excess electrolyte concentration.
The zwitterionic phospholipid bilayers were deposited on silica
surfaces (electric surface potential−40 mV and contact angle of b10°
[19]) by co-adsorption from a mixed micellar solution containing 60/
40 mol/mol DOPC/cholesterol, 60/40 mol/mol DOPC/ergosterol, or
DOPC, and n-dodecyl-β-D-maltoside (DDM; ≥98% purity, Sigma-
Aldrich, St. Louis, MO), as described in detail previously [17]. In brief,
the mixedmicellar solution was formed by addition of 19 mMDDM in
water to DOPC, DOPC/cholesterol (60/40 mol/mol) or DOPC/ergos-
terol (60/40) dry lipid ﬁlms, followed by stirring over night, yielding a
solution containing 97.3 mol% DDM. This micellar solution was added
to the cuvette at 25 °C, and the following adsorption monitored as a
function of time. When adsorption had stabilised, rinsing with Milli-Q
water at 5 ml/min was initiated to remove mixed micelles from
solution and surfactant from the substrate. By repeating this
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micellar solution, stable and densely packed bilayers are formed,
with structural characteristics similar to those of bulk lamellar
structures of the lipids [17,20].
As sub-bilayer and patchy adsorption resulted from the above
mixed micelle approach in the case of the anionic lipid mixture,
supported lipid bilayers were generated from liposome adsorption in
this case. DOPE/DOPG (75/25 mol/mol) and E. coli liposomes were
prepared as described above, but the dried lipid ﬁlms resuspended in
Tris buffer only with no CF present. In order to avoid adsorption of
peptide directly at the silica substrate through any defects of the
supported lipid layer, poly-L-lysine (Mw=170 kDa, Sigma-Aldrich, St.
Louis, MO) was preadsorbed from water prior to lipid addition to an
amount of 0.045±0.01 mg/m2, followed by removal of nonadsorbed
poly-L-lysine by rinsing with water at 5 ml/min for 20 min. Water in
the cuvette was then replaced by buffer containing also 150 mMNaCl,
which was followed by addition of liposomes in buffer at a lipid
concentration of 20 μM, and subsequently by rinsing with buffer
(5 ml/min for 15 min) when the liposome adsorption had stabilised.
The ﬁnal layer formed had structural characteristics (thickness 40±
10 Å, mean refractive index 1.47±0.026) similar to those of the
zwitterionic bilayers, which suggests that a layer fairly close to a
complete bilayer is formed. Again, the bilayer build-upwas performed
at 25 °C.
After lipid bilayer formation, temperature was raised and the
cuvette content replaced by 10 mM Tris buffer at a rate of 5 ml/min
over a period of 30 min. After stabilization for 40 min, peptide was
added to a concentration of 0.01 μM, followed by three subsequent
peptide additions to 0.1 μM, 0.5 μM and 1 μM, in all cases monitoring
the adsorption for 1 h. All measurements were made in at least
duplicate.
2.13. Langmuir balance
Surface pressure on spread lipid monolayers was monitored by
Langmuir balance measurements, using KSV LayerBuilder instrumen-
tation and a Minimicro Teﬂon® trough (KSV, Helsinki, Finland) with a
maximum area of 8350 mm2. Two hydrophilic (Delrin) interlinked
barriers sliding on top of the trough provide symmetric compression.
Trough and barriers were cleaned extensively, ﬁrst in ethanol, and
subsequently in water, and were thereafter dried with ﬁltered
nitrogen gas. The trough was then ﬁlled with degassed and ﬁltered
10 mM Tris buffer, pH 7.4, and aspirated until no trace of surface
contaminants were present, judged from the air–water surface
tension. Lipid was dissolved in chloroform and added drop-wise to
the interface and the solvent was allowed to evaporate. Lipid was
added until a surface pressure of about 28 mN/m was reached, after
which the monolayer was compressed to a surface pressure of 30 mN/
m. After equilibration for 20 min for stabilization, 100 μl peptide
solution (10 mM Tris, pH 7.4) was added to the subphase to a ﬁnal
peptide concentration of 1.0 μM, and additional surface pressure
build-up from peptide incorporated in the phospholipid monolayer
monitored. Measurements were performed in duplicate at 25 °C, and
in an inert nitrogen atmosphere, since it has previously been shown
that Langmuir ﬁlms of phospholipids can be subject to oxidation [21].
3. Results and discussion
As previously demonstrated for peptides derived from kininogen,
end-tagging promotes peptide binding to phospholipid membranes,
resulting in increased membrane lysis in both model lipid liposomes
and bacteria, only weakly depending on which terminal that was used
for end-tagging [10,11]. The same applies also to the presently
investigated GRR10 peptide, where GRR10W4N potently induces
leakage in liposomes at both high and low ionic strength, whereas the
non-tagged GRR10 and GRR10N display very limited liposomeleakage induction (Supporting Material, Figure S1). (As seen here,
amidation of the N-terminus has no effect on the membrane
interaction for this peptide, and will not be discussed further.)
Investigating effects of lipid membrane composition on liposome
rupture for GRR10W4N further demonstrates a striking dependence
on the nature of the lipid membrane. Thus, while peptide-induced
liposome leakage is quite limited for the zwitterionic DOPC, DOPC/
cholesterol, and DOPC/ergosterol membranes, that for the anionic
DOPE/DOPG and E. colimembranes is much more extensive (Fig. 1, as
well as Supporting Material, Figure S2). Although qualitatively similar
to membrane selectivity displayed by a host of AMPs, quantitatively,
the selectivity between anionic and zwitterionic membranes ob-
served for GRR10W4N is signiﬁcantly more pronounced, exempliﬁed
by results obtained for the benchmark peptides LL-37 and omiganan
(Fig. 1c–d).
In addition, there is a pronounced inﬂuence of the presence of a
sterol in the lipid membrane, and of the nature of the sterol. Thus,
while peptide-induced liposome leakage reaches a limiting value of
about 35% and 20% for DOPC in the absence of sterol at low and high
ionic strength, respectively, the additional presence of cholesterol in
the membrane drastically reduces the peptide-induced liposome lysis
further, while replacing cholesterol (present in human cell mem-
branes) with ergosterol (present in fungi) results in about the same
peptide-induced liposome rupture as that observed for DOPC in the
absence of sterol (Fig. 1).
Investigating these effects of membrane composition further,
peptide adsorption to the lipid membranes was monitored with
ellipsometry. As can be seen in Fig. 2, there is a close correlation
between peptide-induced liposome leakage and peptide adsorption
density at the lipid membrane. Thus, the anionic DOPE/DOPG
and E. coli membranes display high adsorption of GRR10W4N, cor-
responding to a peptide-to-lipid ratio of about 1:10 at the highest
peptide concentration investigated. For the zwitterionic membranes,
on the other hand, peptide adsorption is substantially lower,
reﬂecting the lower electrostatic potential of these membranes
(≈−8–10 mV compared to −35–40 mV for the anionic membranes
[12,20]; such a (marginal) electrostatic potential of PC and PE
membranes is well established in literature [22,23] and has been
ascribed either to the ﬁnite separation between the positive and
negative charge in the zwitterionic group affecting counterion
distribution and resulting in a pKa shift for the phosphate group
[24], presence of small amounts of fatty acid impurities from minute
phospholipid hydrolysis, or surface anrichment of polarizable anions
[25].) Interestingly, however, while DOPC/cholesterol displayedmuch
lower peptide-induced liposome leakage than DOPC and DOPC/
ergosterol, a comparable, or even slightly higher adsorption is
observed for DOPC/cholesterol than for the other two zitterionic
membranes, indicating differences in the degree of membrane
incorporation of the adsorbed peptide between these zwitterionic
membranes.
In order to investigate these effects further, we performed a series
of experiments to address the issue of membrane incorporation. In the
ﬁrst of these, W ﬂuorescence spectra of GRR10W4N were monitored
in buffer with and without liposomes present. As can be seen in Fig. 3,
there are onlyminor differences between the spectra, small compared
to substantial effects observed on peak position and intensity for
tryptophans in non-polar environments. Since W ﬂuorescence is
highly sensitive to the polarity of the ambient [26], the emission peak
at≈360 nm shows that the W residues of GRR10W4N are exposed to
the aqueous solution. Furthermore, CD spectroscopy demonstrates
that there is little or no helix induction in GRR10 or GRR10N in the
presence of the phosholipid membrane (helix content for both lipids
in Tris buffer and in the presence of DOPE/DOPG or DOPC/cholesterol
liposomes 7±2%), excluding ordered transmembrane structures
(Fig. 4). While the CD spectra for GRR10W4N is complicated due to
the CD signal of theW side chain [12], the lack of signal in the 215-nm
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Fig. 2. Adsorption of GRR10W4N to lipid bilayers in 10 mM Tris, pH 7.4. The adsorption
of the WWW tripeptide alone was less than 40 nmol/m2 throughout.
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also for GRR10W4N. Taken together, ﬂuorescence and CD spectros-
copy shows that GRR10W4N binds to phospholipid membranes
within, or close to, the polar headgroup region in the membrane. This
is in agreement with previous ﬁndings that bulky and polarizable W
(and F) residues have an afﬁnity to interfaces, and are frequently
located in the proximity of the polar headgroup region in phospho-
lipid membranes [27–33]. In the case of antimicrobial peptides,
related ﬁndings have been reported, e.g., by Glukhov et al.,
demonstrating sequence-dependent penetration of KKKKKKAAXAA-
WAAXAA (X being W or F) of 2.5–8 Å [27], while, Li et al. investigated
aurein 1.2 analogs and found the F residues in these peptides to
penetrate 2–5 Å below the polar headgroup region [28]. Also recent
NMR ﬁndings by Orädd et al. for a W-modiﬁed variant of the
complement-derived peptide CNY21 support this notion [34].
Monitoring effect of membrane composition on peptide insertion
was alsomonitoredmore directly by Langmuir balance. As can be seen
in Fig. 5 and Fig. S3 (Supporting Material), GRR10W4N is able to
incorporate into both zwitterionic and anionic phospholipid mono-
layers. As expected and as previously observed [35–40], peptide
incorporation decreases with increasing monolayer pressure
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Fig. 3. Tryptophan ﬂuorescence spectra, at a peptide concentration of 10 μM, for
GRR10W4N in 10 mM Tris, pH 7.4, with or without additional 150 mM NaCl, in the
presence and absence of (a) DOPE/DOPG (75/25 mol/mol) or (b) DOPC/cholesterol (60/
40 mol/mol) liposomes (100 μM lipid).
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peptide incorporation is much more extensive for anionic than for
zwitterionic membranes, both therefore contributing to the higher
peptide-induced membrane rupture found for the anionic membranes
(Fig. 5; Supporting Material, Fig. 3). A similar more extensive peptide
incorporation in anionic phospholipid monolayers was observed by
Sanchez-Martin et al. for E1(145–162) hepatitis G virus peptide for
dimyrostoylphosphatidylcholine and dimyrostoylphosphatidylglycerol
monolayers [36]. Similarly, Won and Ianoul found the peptide pEM-2
(KKWRWWLKALAKK) to be more extensively incorporated in anionic
monolayers (dioleoylphosphatidylglycerol and E. coli lipid extract) than
in a zwitterionic dioleoylphosphatidylcholinemonolayer at low surface
pressures (7.5 mN/m), as well as continued peptide incorporation
(although quantitatively smaller) in the anionic monolayers, but
complete exclusion of the peptide from the zwitterionic monolayer
at high surface pressure (30 mN/m) [37]. Although complicated by
peptide self-assembly, a similar increased peptide incorporation
with increasing monolayer negative charge was found by Thakuret al. for Aβ [1–40] in palmitoyloleoylphosphatidylcholine/
palmitoyloleoylphosphatidylglycerol and dipamitoylphosphatidyl-
choline/ganglioside GM1 mixed monolayers [38]. In the presence of
cholesterol, peptide incorporation into DOPC monolayers is further
precluded, an effect due to the membrane condensing effects of
cholesterol [41–43]. For example, Henriksen et al. monitored the
effect of sterols on palmityloleoylphosphatidylcholine (POPC) lipo-
somes by micropipette aspiration, and found cholesterol to potently
increase the membrane expansion modulus in a concentration-
dependent manner, while the effect of ergosterol was much smaller
[42]. Furthermore, in analogy to the present results (Fig. 5)
cholesterol has previously been found to reduce peptide incorpora-
tion into lipid monolayers. Thus, Azouzi et al. investigated effects of
cholesterol content in mixed monolayers for the cyclic peptide
cyclosporine A and found the exclusion pressure of this peptide to
decrease linearly with the cholesterol content [39]. Similarly, Sood et
al. found cholesterol to cause a decrease of LL-37 incorporation into
stearolyloleoyl monolayers over the entire surface pressure range, as
well as the peptide exclusion pressure [40]. In line with the overall
conclusions from the present investigation, the authors of the latter
report summarized the origin of the distinction between target
and host cell (although being less pronounced for LL-37 than
for the presently investigated peptides (Fig. 1)) to originate from
a combination of an enhanced peptide binding to anionic phospho-
lipids, and an attenuation of peptide interactions from choles-
terol and sphingomyelin. Taken together, the presently reported
Langmuir monolayer results are therefore in good agreement with
results from investigations previously reported in literature.
The presently observed membrane selectivity is expected to be of
relevance for the functional performance of AMPs. Thus, human cell
membranes and bacterial membranes have similar functions but
differ in composition. For example, in the membrane of red blood
cells, phosphatidylcholine (PC) and sphingomyelin (SM) are abun-
dant in the outer layer, while the inner leaﬂet mainly contains amino
lipids (phosphatidylethanolamine (PE) and phosphatidylserine (PS)).
These lipids are zwitterionic (except for PS), rendering the outer part
of the membrane essentially uncharged. On the contrary, the outer
membrane of bacteria is rich in anionic lipids. For example, the
cytoplasmic membrane of E. coli typically (although varying between
strains, between different growth conditions, etc.) contains 82% PE, 6%
PG, and 12% cardiolipin [44]. S. aureusmembranes, on the other hand,
contain PG lipids only, typically of the order 36% PG, 7% cardiolipin,
and 57% lysylPG [45]. In addition, cholesterol is present in human cell
membranes, constituting up to 45% of the total lipids, while it is absent
in bacterial membranes, or replaced by ergosterol in fungi. Although
these sterols are structurally quite similar, their relative effects on
membranes differ substantially. Cholesterol is particularly potent in
increasing lipid order in membranes while maintaining ﬂuidity, and
provides large mechanical coherence to membranes [39–43]. As
cholesterol condenses the phospholipid bilayer, peptide adsorption
and penetration become sensitive to cholesterol, while ergosterol has
more marginal membrane-condensing effects and confers less
stability to phospholipid membranes. Particularly for bulky aromatic
groups such as W and F, which require substantial area expansion,
insertion into membranes containing cholesterol becomes an ener-
getically costly process. Examples of peptides particularly sensitive to
the presence of cholesterol are therefore those containing aromatic
oligopeptide residues, such as those discussed here.
Given this difference between cholesterol and ergosterol, identi-
ﬁcation of peptides which are selective for ergosterol-containing
membranes may therefore represent a means to achieve simulta-
neously antifungal and low-toxic therapeutics. In this context, we
previously investigated histidine-rich glycoprotein (HRG) and smaller
peptide sequences thereof [46]. HRG exerts potent antifungal activity
at low pH, mediated via its histidine-rich region, as do small peptides
originating from this region. HRG was furthermore found to protect
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demonstrated that HRG causedmembrane breaks in Candida cells and
release of cytoplasmic components in vitro. In parallel, HRGwas found
to disrupt liposomes. Notably, ergosterol-containing liposomes,
mimicking fungal membranes, were more sensitive than cholester-
ol-containing ones, mimicking mammalian membranes. Through this
selectivity, HRG is able to mediate antifungal effects, at the same time
as it displays low toxicity toward human cells.
Although the discussion above has focused on GRR10W4N, we note
that high membrane selectivity is a general feature of short, highly
charged, and hydrophilic peptides end-taggedwith short aromatic amino
acid sequences. Thus, GKK10W4, containing lysines rather than arginines
as in GRR10W4, provides a similar pronounced selectivity to bacteria-
mimicking DOPE/DOPG membranes over DOPC/cholesterol membranes
mimicking mammalian cell membranes (Fig. 6a). Similarly, replacing W
with F in the end-tags results in a similar preferential membrane lysis
(Fig. 6b). Taking another peptide sequence altogether of a similar type, i.e.,
short, highly charged, and hydrophilic (KNK10, KNKGKKNGKH, derived
from human kininogen [11]) also results in a similar pronounced
selectivity (Fig. 6c). Thus, short and hydrophilic peptides containing a
high content of positive charges distributed throughout the peptide,
combined with aromatic amino acid end-tags seem to provide a general
approach for identifying highly selective AMPs.
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selectivity displayed by GRR10W4N and structurally related peptides
at the phospholipid membrane level, biological assays were per-
formed tomonitor the antimicrobial potency of this peptide, as well as
its toxicity to human cell lines. As shown in Fig. 7, GRR10W4N indeed
displays potent antimicrobial potency against both Gram-positive
S. aureus, Gram-negative E. coli and P. aeruginosa, and the fungi
C. albicans and C. parapsilosis, also at the physiological ionic strength
under which these measurements were performed. (Similar results
were found for GRR10F5 (Supporting Material, Fig. S4), in analogy to
the structural generalization demonstrated for liposomes in Fig. 6. In
addition, the assay independence in regards to the effect of end-
tagging was demonstrated by including also data on minimum
inhibitory concentration (MIC) (Supporting Material, Table S1), as
well as viable count assay data in 10 mM Tris, pH 7.4, 150 mM NaCl,
with additional 20% citrate plasma (Supporting Material, Figure S5),
the latter demonstrating bactericidal rather than bacteriostatic
effects.) Quantitatively, within the limitations of the RDA assay, the
antimicrobial effect of GRR10W4N against Gram-negative E. coli and
Gram-positive S. aureus is comparable to that of late phase clinical
trials peptide omiganan, and exceeds that of the benchmark peptide
LL-37. For Gram-negative P. aeruginosa, GRR10W4N was signiﬁcantly
more potent than both benchmark peptides. For the fungi C. albicans
and C. parapsilosis, GRR10W4N displays much stronger inhibitory
effects than both omiganan and LL-37. Taken together, the combined
data demonstrate the effectiveness of W-tagged AMP against both
bacteria and fungi. At the same time, however, toxicity of GRR10W4N
to human cells is limited. As shown in Fig. 8, GRR10W4N displays very
low hemolysis, comparable to that of the negative control, up to
120 μM, as well as low toxicity towards human keratinocytes.
Quantitatively, both LDH and MTT assays indicate a toxicity level of
GRR10W4N comparable to that of omiganan, particularly clearly seen
at 30 μM. For LL-37, both LDH and MTT assays indicate signiﬁcant
toxicity to human keratinocytes as well as human erythrocytes. In
order to further illustrate the selectivity of GRR10W4N between
bacteria and erythrocytes, citrate–blood was supplemented with
either S. aureus or P. aeruginosa, whereafter peptide was added, and
hemolysis and bacteria viable count assays performed on the same
sample. As can be seen in Fig. 9, LL-37 displays higher hemolysis than
the other peptides also in citrate–blood, whereas hemolysis in the
presence of the other peptides is comparable to that of the negative
control. As expected, GRR10N displays very modest antimicrobial
effect against S. aureus and P. aeruginosa in blood, in agreement with
the RDA results for Tris buffer in Fig. 7. Also analogous to ﬁndings from
the simpler RDA assay in buffer, GRR10W4N displays potent
antimicrobial effects against S. aureus, which exceed those of
omiganan and LL-37, while for P. aeruginosa, antimicrobial effects
for GRR10W4N and LL-37 are comparable, and signiﬁcantly stronger
than that of omiganan. Taken together, the data in Figs. 7–9
demonstrates a striking selectivity for GRR10W4N, with potent
broad spectrum effects combined with low cell toxicity. They also
show that the selectivity displayed by GRR10W4N on the phospho-
lipid membrane level translates to a pronounced membrane selectiv-
ity on the microbial/cellular level.
As a ﬁnal point, we note the structural similarity between the
presently investigated peptides and that of other P- and R-rich
peptides, such as Bac7 peptides [47], prophenin [48–50], and
tritrypticin [51,52]. As reported, e.g., by Benicasa et al., some of
these peptides act also in a non-lytic manner, having an active
transport system for membrane passage, and being selectively active
on Gram-negative bacteria [47]. Although suchmechanisms cannot be
excluded at present for GRR10W4N and related peptides, we note that
(i) similar bactericidal effects are observed also for Gram-positive S.
aureus and the fungus C. albicans and (ii) there is a good correlation
between bactericidal effect and liposome rupture, both arguing
against substantial non-lytic internalization processes.
Fig. 7. Antimicrobial effect, as determined by radial diffusion assay (RDA) in 10 mM Tris, pH 7.4, with additional 150 mMNaCl, of GRR10W4N (10 and 50 μM) against Gram-positive
S. aureus, and Gram-negative P. aeruginosa and E. coli, and fungi C. albicans and C. parapsilosis clinical isolates. For comparison, corresponding data for the control peptides GRR10,
GRR10N, LL-37, and omiganan are included as well. In RDA, peptides are placed in wells in agar gels containing conﬂuent microbes. On radial diffusion, the peptide will kill bacteria
and result in a clearance zone containing disintegrated microbes. Thus, the higher the diameter (d), the higher the growth inhibition, i.e., the more potent the peptide.
Fig. 8. Cytotoxicity of GRR10W4N, monitored by hemolysis, LDH release, and MTT assay. For comparison, data for the control peptides GRR10, GRR10N, LL-37 and omiganan are
included as well.
1089A. Schmidtchen et al. / Biochimica et Biophysica Acta 1808 (2011) 1081–10914. Conclusions
Increasing antimicrobial peptide hydrophobicity through end-
tagging with oligotryptophan promotes peptide-induced lysis of
phospholipid liposomes, as well as bacterial and fungal killing. ForFig. 9. Combined hemolysis (a) and VCA assay (b) for S. aureus and P. aeruginosa (both 2short, hydrophilic, and highly charged peptides, bactericidal potency
after end-tagging is accompanied by limited toxicity for human cells,
as well as low hemolysis. A strikingly selective targeting of bacteria
membrane was demonstrated in experiments where bacteria-sup-
plemented blood was exposed to peptides. The functional selectivity×108 cfu/ml) added to 50% citrate–blood, at the indicated peptide concentrations.
1090 A. Schmidtchen et al. / Biochimica et Biophysica Acta 1808 (2011) 1081–1091thus displayed is, at least in part, due to a pronounced selectivity of
such peptides for anionic lipid membranes, combined with sensitivity
to the presence of cholesterol. As demonstrated for GRR10W4N
(GRRPRPRPRPWWWW-NH2), potent liposome rupture occurs for
anionic lipid systems (DOPE/DOPG and E. coli lipid extract) while that
of zwitterionic DOPC/cholesterol ones is largely absent under the
conditions investigated. This striking membrane selectivity is due to a
combination of a lower peptide binding density to the zwitterionic
membranes (z≈−8–10 mV) than to the anionic ones (z≈−35–
40 mV), and a lower degree of peptide insertion into the membrane
for the zwitterionic membrane, particularly in the presence of
cholesterol, which opposes the substantial area expansion required
to incorporate the peptide at these concentrations, particularly since
the W residues also after membrane incorporation remain within (as
opposed to on top of), the polar headgroup region. Removing
cholesterol or more interestingly replacing cholesterol with ergoster-
ol, thus mimicking fungal membranes, results in an increased
sensitivity for peptide-induced lysis, and demonstrates a possibility
for antifungal peptides displaying limited toxicity, also supported
directly by antifungal and toxicity data. Given the importance of lipid
rafts in many contexts of membrane biochemistry and biophysics, it
would be interesting to investigate effects of cholesterol in the
presence of sphingomyelin and raft formation. However, with
numerous intricacies relating to, e.g., sterol and sphingomyelin
structure, but also to acyl length, saturation, branching, and
assymetry, as well as to the polar headgroup, of phospholipid
components in the membrane, not to mention composition of the
3+-component system, doing these complex issues justice requires a
separate investigation. Finally, W-tagging of short, hydrophilic, and
highly charged AMPs seems to be a general approach for designing
simultaneously potent and low-toxic AMPs.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamem.2010.12.020.
Acknowledgements
This work was supported by the Swedish Research Council
(projects 621-2009-3009 and 521-2009-3378, 7480) and Dermagen
AB. Ms. Lise-Britt Wahlberg and Ms. Mina Davoudi are gratefully
acknowledged for technical support.
References
[1] G.L. French, Clinical impact and relevance of antibiotic resistance, Adv. Drug Deliv.
Rev. 57 (2005) 1514–1527.
[2] M. Zasloff, Antimicrobial peptides of multicellular organisms, Nature 415 (2002)
389–395.
[3] A.K. Marr, W.J. Gooderham, R.E. Hancock, Antibacterial peptides for therapeutic
use: obstacles and realistic outlook, Curr. Opin. Pharmacol. 6 (2006) 468–472.
[4] A. Tossi, L. Sandri, A. Giangaspero, Amphipathic, alpha-helical antimicrobial
peptides, Biopolymers 55 (2000) 4–30.
[5] K.A. Brogden, Antimicrobial peptides: pore formers or metabolic inhibitors in
bacteria? Nat. Rev. Microbiol. 3 (2005) 238–250.
[6] V. Nizet, Antimicrobial peptide resistance mechanisms of human bacterial
pathogens, Curr. Issues Mol. Biol. 8 (2006) 11–26.
[7] H.W. Huang, Molecular mechanism of antimicrobial peptides: the origin of
cooperativity, Biochim. Biophys. Acta 1758 (2006) 1292–1302.
[8] R.E. Hancock, H.G. Sahl, Antimicrobial and host-defense peptides as new anti-
infective therapeutic strategies, Nat. Biotechnol. 24 (2006) 1551–1557.
[9] A.A. Strömstedt, L. Ringstad, A. Schmidtchen, M. Malmsten, Interaction between
amphiphilic peptides and phospholipid membranes, Curr. Opin. Colloid Interface
Sci. 15 (2010) 467–478.
[10] A. Schmidtchen, M. Pasipuleti, M. Mörgelin, M. Davoudi, J. Alenfall, A. Chalupka,
M. Malmsten, Boosting antimicrobial peptides by hydrophobic amino acid end-tags,
J. Biol. Chem. 284 (2009) 17584–17594.
[11] M. Pasupuleti, A. Schmidtchen, A. Chalupka, L. Ringstad, M. Malmsten, End-
tagging of ultra-short antimicrobial peptides by W/F stretches to facilitate
bacterial killing, PLoS One 4 (e5285) (2009) 1–9.
[12] A.A. Strömstedt, M. Pasupuleti, A. Schmidtchen, M. Malmsten, Oligotryptophan-
tagged antimicrobial peptides and the role of the cationic sequence, Biochim.
Biophys. Acta 1788 (2009) 1916–1923.
[13] M. Malmsten, M. Davoudi, A. Schmidtchen, Bacterial killing by heparin-binding
peptides from PRELP and thrombospondin, Matrix Biol. 25 (2006) 294–300.[14] R.I. Lehrer, M. Rosenman, S.S. Harwig, R. Jackson, P. Eisenhauer, Ultrasensitive
assays for endogenous antimicrobial polypeptides, J. Immunol. Methods 137
(1991) 167–173.
[15] E. Andersson, V. Rydengard, A. Sonesson, M. Mörgelin, L. Bjorck, A. Schmidtchen,
Antimicrobial activities of heparin-binding peptides, Eur. J. Biochem. 271 (2004)
1219–1226.
[16] M. Malmsten, Ellipsometry studies of protein layers adsorbed at hydrophobic
surfaces, J. Colloid Interface Sci. 166 (1994) 333–342.
[17] F. Tiberg, I. Harwigsson, M. Malmsten, Formation of model lipid bilayers at the
silica-water interface by co-adsorption with non-ionic dodecyl maltoside
surfactant, Eur. Biophys. J. 29 (2000) 196–203.
[18] J.A. De Feijter, J. Benjamins, F.A. Veer, Ellipsometry as a tool to study the
adsorption behavior of synthetic and biopolymers at the air–water interface,
Biopolymers 17 (1978) 1759–1772.
[19] M. Malmsten, N. Burns, A. Veide, Electrostatic and hydrophobic effects of
oligopeptide insertions on protein adsorption, J. Colloid Interface Sci. 204
(1998) 104–111.
[20] L. Ringstad, A. Schmidtchen, M. Malmsten, Effect of peptide length on the
interaction between consensus peptides and DOPC/DOPA bilayers, Langmuir 22
(2006) 5042–5050.
[21] J.F.D. Liljeblad, V. Bulone, E. Tyrode, M.W. Rutland, C.M. Johnson, Phospholipid
monolayers probed by vibrational sum frequency spectroscopy: instability of
unsaturated phospholipids, Biophys. J. 98 (2010) L50–L52.
[22] C. Matos, B. de Castro, P. Gameiro, J.L.F.C. Lima, S. Reis, Zeta-potential
measurements as a tool to quantify the effect of charged drugs on the surface
potential of egg phosphatidylcholine liposomes, Langmuir 20 (2004) 369–377.
[23] M.T. Roy, M. Gallardo, J. Estellrich, Inﬂuence of size on electrokinetic behavior of
phosphatidylserine and phosphatidylethanolamine lipid vesicles, J. Colloid
Interface Sci. 206 (1998) 512–517.
[24] M.R. Moncelli, L. Becucci, R. Guidelli, The intrinsic pKa values for phosphatidyl-
choline, phosphatidylethanolamine, and phosphatidylserine in monolayers
deposited on mercury electrodes, Biophys. J. 66 (1994) 1969–1980.
[25] M. Boström, D.R.M.Williams, B.W.Ninham, Surface tension of electrolytes: speciﬁc
ion effects explained by dispersion forces, Langmuir 17 (2001) 4475–4478.
[26] K. Lotte, R. Plessow, A. Brockhinke, Static and time-resolved ﬂuorescence
investigations of tryptophan analogues—a solvent study, Photochem. Photobiol.
Sci. 3 (2004) 348–359.
[27] E. Glukhov, M. Stark, L.L. Burrows, C.M. Deber, Basis for selectivity of cationic
antimicrobial peptides for bacterial versus mammalian membranes, J. Biol. Chem.
280 (2005) 33960–33967.
[28] X. Li, Y. Li, A. Peterkofsky, G. Wang, NMR studies of aurein 1.2 analogs, Biochim.
Biophys Acta 1758 (2006) 1203–1214.
[29] E.F. Hanley, F. Lau, H.J. Vogel, Solution structures and model membrane
interactions of lactoferrampin, an antimicrobial peptide derived from bovine
lactoferrin, Biochim. Biophys. Acta 1768 (2007) 2355–2364.
[30] J.E. McInturff, S.-J. Wang, T. Machleidt, T.R. Lin, A. Oren, C.J. Hertz, S.R. Krutzik,
S. Hart, K. Zeh, D.H. Anderson, R.L. Gallo, R.L. Modlin, J. Kim, Granulysin-derived
peptides demonstrate antimicrobial and anti-inﬂammatory effects against
Propionibacterium acnes, J. Invest. Dermatol. 125 (2005) 256–263.
[31] B. Deslouches, S.M. Phadke, V. Lazarevic, M. Cascio, K. Islam, R.C. Montelaro,
T.A. Mietzner, De novo generation of cationic antimicrobial peptides: inﬂuence of
length and tryptophan substitution on antimicrobial activity, Antimicrob. Agents
Chemother. 49 (2005) 316–322.
[32] M.R.R. de Planque, J.A.W. Kruijtzer, R.M. Liskamp, D. Marsh, D.V. Greathouse,
R.E. Koeppe, B. de Kruijff, J.A. Killian, Different membrane anchoring positions of
tryptophan and lysine in synthetic transmembrane α-helical peptides, J. Biol.
Chem. 274 (1999) 20839–20846.
[33] V.V. Andrushchenko, H.J. Vogel, E.J. Prenner, Interactions of tryptophan-rich
cathelicidin antimicrobial peptides withmodel membranes studied by differential
scanning calorimetry, Biochim. Biophys. Acta 1768 (2007) 2447–2458.
[34] G. Orädd, A. Schmidtchen, M. Malmsten, Effects of peptide hydrophobicity on its
incorporation in phospholipid membranes — an NMR and ellipsometry study,
Biochim. Biophys. Acta 1808 (2010) 244–252.
[35] M. Arseneault, S. Bédard, M. Boulet-Audet, M. Pézolet, Study of the interaction of
lactoferricin B with phospholipid monolayers and bilayers, Langmuir 26 (2010)
3468–3478.
[36] M.J. Sanchez-Martin, I. Haro, M.A. Alsina, M.A. Busquets, M. Pujol, A Langmuir
monolayer study of the interaction of E1(145-162) hepatitis G virus peptide with
phospholipid membranes, J. Phys. Chem. B 114 (2010) 448–456.
[37] A. Won, A. Ianoul, Interactions of antimicrobial peptide from C-terminus of
myotoxin II with phospholipid mono- and bilayers, Biochim. Biophys. Acta 1788
(2009) 2277–2283.
[38] G. Thakur, M. Micic, R.M. Leblanc, Surface chemistry of Altzheimer's disease: a
Langmuir monolayer approach, Colloids Surf. B 74 (2009) 436–456.
[39] S. Azouzi, K. El Kirat, S. Morandat, The potent antimalarial drug cyclosporine A
preferentially destabilizes sphingomyelin-rich membranes, Langmuir 26 (2009)
1960–1965.
[40] R. Sood, Y. Domanov, M. Pietiänen, V.P. Kontinen, P.K.J. Kinnunen, Binding of LL-37
to model biomembranes: insight into target vs host cell recognition, Biochim.
Biophys. Acta 1778 (2008) 983–996.
[41] O.G. Mouritsen, M.J. Zuckermann, What's so special about cholesterol? Lipids 39
(2004) 1101–1113.
[42] J. Henriksen, A.C. Rowat, E. Brief, Y.W. Hsueh, J.L. Thewalt, M.J. Zuckermann, J.H. Ipsen,
Universal behavior of membranes with sterols, Biophys. J. 90 (2006) 1639–1649.
[43] H. Ohvo-Rekilä, B. Ramstedt, P. Leppimäki, P. Slotte, Cholesterol interactions with
phospholipis in membranes, Progr. Lipid Res. 41 (2002) 66–97.
1091A. Schmidtchen et al. / Biochimica et Biophysica Acta 1808 (2011) 1081–1091[44] E.J.J. Lugtenberg, R. Peters, Distribution of lipids in cytoplasmic and outer
membranes of Escherichia coli K12, Biochim. Biophys. Acta 441 (1976) 38–47.
[45] C.W. Haest, J. de Gier, J.A. den Kamp, P. Bartels, L.L. van Deenen, Changes in
permeability of Staphylococcus aureus and derived liposomes with varying lipid
composition, Biochim. Biophys. Acta 255 (1972) 720–733.
[46] V. Rydengård, O. Shannon, K. Lundqvist, L. Kacprzyk, A. Chalupka, A.-K. Olsson,
M. Mörgelin, W. Jahnen-Dechent, M. Malmsten, A. Schmidtchen, Histidine-rich
glycoprotein protects from systemic Candida infection, PLoS Pathogens 4
(e1000116) (2008) 1–11.
[47] M. Benicasa, C. Pelillo, S. Zoret, C. Garrovo, S. Bifﬁ, R. Gennaro, M. Scocchi, The
proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium
in a mouse infection model, BMC Microbiology 10 (178) (2010) 1–8.
[48] Y. Wang, W.J. Grifﬁths, T. Curstedt, J. Johansson, Porcine pulmonary preparations
contain the antibacterial peptide prophenine and a C-terminal 18-residue
fragment thereof, FEBS Letts. 460 (1999) 257–262.[49] Y. Wang, J. Johansson, W.J. Grifﬁths, Characterisation of variant forms of
prophenin: mechanistic aspects of the fragmentation of proline-rich peptides,
Rapid Comm. Mass Spectrom. 14 (2000) 2182–2202.
[50] S.S.L. Harwig, V.N. Kokryakov, K.M. Swiderek, G.M. Aleshina, C. Zhao, R.I. Lehrer,
Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine
leukocytes, FEBS Letts. 362 (1995) 65–69.
[51] S. Nagpal, V. Gupta, K.J. Kaur, D.M. Salunke, Structure-function analysis of
tritrypticin, an antibacterial peptide of innate immune origin, J. Biol. Chem. 274
(1999) 23296–23304.
[52] K.J. Kaur, P. Sarkar, S. Nagpal, T. Khan, D.M. Salunke, Structure-function analyses
involving palindromic analogs of tritrypticin suggest autonomy of anti-endotoxin
and antibacterial activities, Protein Sci. 17 (2008) 545–554.
[53] D. Eisenberg, E. Schwarz, M. Komaromy, R. Wall, Analysis of membrane and
surface protein sequences with the hydrophobic moment plot, J. Mol. Biol. 179
(1984) 125–142.
